Toxoplasmosis: Targeting neurotransmitter systems in psychiatric disorders

Abdoli A, Dalimi A, Arbabi M, Ghaffarifar F (2014) Neuropsychiatric manifestations of latent toxoplasmosis on mothers and their offspring. J Matern-Fetal Neonatal Med 27(13):1368–1374. https://doi.org/10.3109/14767058.2013.858685CrossRefPubMed

Abedalthagafi M, Rushing EJ, Garvin D, Cheson B, Ozdemirli M (2009) Asymptomatic diffuse “encephalitic” cerebral toxoplasmosis in a patient with chronic lymphocytic leukemia: case report and review of the literature. Int J Clin Exp Pathol 3(1):106–109PubMed

Abg Abd Wahab DY, Gau CH, Zakaria R, Muthu Karuppan MK, BS AR, Abdullah Z, Alrafiah A, Abdullah J M, Muthuraju S, (2019) Review on cross talk between neurotransmitters and neuroinflammation in striatum and cerebellum in the mediation of motor behaviour. BioMed Res Int 2019:1767203. https://doi.org/10.1155/2019/1767203CrossRefPubMedPubMedCentral

Abo-Al-Ela HG (2019) Toxoplasmosis and psychiatric and neurological disorders: a step toward understanding parasite pathogenesis. ACS Chem Neurosci 11(16):2393–2406. https://doi.org/10.1021/acschemneuro.9b00245CrossRefPubMed

Ahlquist RP (1948) A study of the adrenotropic receptors. Am J Physiol C 153(3):586–600. https://doi.org/10.1152/ajplegacy.1948.153.3.586CrossRefPubMed

Ahmadpour E, Daryani A, Sharif M, Sarvi S, Aarabi M, Mizani A, Rahimi MT, Shokri A (2014) Toxoplasmosis in immunocompromised patients in Iran: a systematic review and meta-analysis. J Infect Dev Ctries 8(12):1503–1510. https://doi.org/10.3855/jidc.4796CrossRefPubMed

AL-Hadad MTS, Kadhim RA, Al-Rubaye AF (2019) Effect of chronic toxoplasmosis on levels of some neurotransmitters (Dopamine, Adrenaline, and Noradrenaline) in human serum. Int J Pharm Sci Res 11(2):402–405

Alonso R, Chaudieu I, Diorio J, Krishnamurthy A, Quirion R, Boksa P (1993) Interleukin-2 modulates evoked release of [3H] dopamine in rat cultured mesencephalic cells. J Neurochem 61(4):1284–1290. https://doi.org/10.1111/j.1471-4159.1993.tb13620.xCrossRefPubMed

Amouei A, Moosazadeh M, Nayeri Chegeni T, Sarvi S, Mizani A, Pourasghar M, Hosseini Teshnizi S, Hosseininejad Z, Dodangeh S, Pagheh A, Pourmand AH, Daryani A (2020) Evolutionary puzzle of Toxoplasma gondii with suicidal ideation and suicide attempts: an updated systematic review and meta-analysis. Transbound Emerg Dis 0:1–14. https://doi.org/10.1111/tbed.13550

Andrade WA, Souza Mdo C, Ramos-Martinez E, Nagpal K, Dutra MS, Melo MB, Bartholomeu DC, Ghosh S, Golenbock DT, T. Gazzinelli R, (2013) Combined action of nucleic acid-sensing Toll-like receptors and TLR11/TLR12 heterodimers imparts resistance to Toxoplasma gondii in mice. Cell Host Microbe 13:42–53. https://doi.org/10.1016/j.chom.2012.12.003CrossRefPubMedPubMedCentral

Andrews N, Barnes NM, Steward LJ, West KE, Cunningham J, Wu PY, Zangrossi H Jr, File SE (1993) A comparison of rat brain amino acid and monoamine content in diazepam withdrawal and after exposure to a phobic stimulus. Br J Pharmacol 109(1):171. https://doi.org/10.1111/j.1476-5381.1993.tb13548.xCrossRefPubMedPubMedCentral

Anisman H, Merali Z, Hayley S (2008) Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog Neurobiol 85(1):1–74. https://doi.org/10.1016/j.pneurobio.2008.01.004CrossRefPubMed

Arango V, Underwood MD, Mann JJ (1996) Fewer pigmented locus coeruleus neurons in suicide victims: preliminary results. Biol Psychiatry 39(2):112–120. https://doi.org/10.1016/0006-3223(95)00107-7CrossRefPubMed

Arnold-Schrauf C, Berod L, Sparwasser T (2015) Dendritic cell specific targeting of MyD88 signalling pathways in vivo. Eur J Immunol 45:32–39. https://doi.org/10.1002/eji.201444747CrossRefPubMed

Asada H, Kawamura Y, Maruyama K, Kume H, Ding R-G, Kanbara N, Kuzume H, Sanbo M, Yagi T, Obata K (1997) Cleft palate and decreased brain γ-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA 94(12):6496–6499. https://doi.org/10.1073/pnas.94.12.6496CrossRefPubMedPubMedCentral

Axelrod J, Kopin I (1969) The uptake, storage, release and metabolism of noradrenaline in sympathetic nerves. Prog Brain Res 31:21–32. https://doi.org/10.1016/S0079-6123(08)63224-0CrossRefPubMed

Ayano G (2016) Common neurotransmitters: criteria for neurotransmitters, key locations, classifications and functions. JAPN 1(1), 1–5. https://doi.org/10.11648/j.ajpn.20160406.12

Bak LK, Schousboe A, Waagepetersen HS (2006) The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 98(3):641–653. https://doi.org/10.1111/j.1471-4159.2006.03913.xCrossRefPubMed

Baxter MG, Murray EA (2002) The amygdala and reward. Nat Rev Neurosci 3(7):563–573. https://doi.org/10.1038/nrn875CrossRefPubMed

Bayani M, Riahi SM, Bazrafshan N, Ray Gamble H, Rostami A (2019) Toxoplasma gondii infection and risk of Parkinson and Alzheimer diseases: a systematic review and meta-analysis on observational studies. Acta Trop 196:165–171. https://doi.org/10.1016/j.actatropica.2019.05.015CrossRefPubMed

Bazemore AEK, Florey E (1956) Factor I and gamma-aminobutyric acid. Nature 178:1052–1053. https://doi.org/10.1038/1781052a0CrossRefPubMed

Beggiato S, Antonelli T, Tomasini MC, Tanganelli S, Fuxe K, Schwarcz R, Ferraro L (2013) Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo. Eur J Neurosci 37(9):1470–1477. https://doi.org/10.1111/ejn.12160CrossRefPubMed

Benarroch EE (2010) Glutamate transporters: diversity, function, and involvement in neurologic disease. J Neurol 74(3):259–264. https://doi.org/10.1212/WNL.0b013e3181cc89e3CrossRef

Benítez-Diaz P, Miranda-Contreras L, Mendoza-Briceño RV, Peña-Contreras Z, Palacios-Prü E (2003) Prenatal and postnatal contents of amino acid neurotransmitters in mouse parietal cortex. Dev Neurosci 25(5):366–374. https://doi.org/10.1159/000073514CrossRefPubMed

Bennett S, Grant MM, Aldred S (2009) Oxidative stress in vascular dementia and Alzheimer’s disease: a common pathology. J Alzheimers Dis 17(2):245–257. https://doi.org/10.3233/jad-2009-1041CrossRefPubMed

Berdoy M, Webster JP, Macdonald DW (2000) Fatal attraction in rats infected with Toxoplasma gondii. Proc Biol Sci 267(1452):1591–1594. https://doi.org/10.1098/rspb.2000.1182CrossRefPubMedPubMedCentral

Berger-Sweeney J, Hohmann CF (1997) Behavioral consequences of abnormal cortical development: insights into developmental disabilities. Behav Brain Res 86(2):121–142. https://doi.org/10.1016/s0166-4328(96)02251-6CrossRefPubMed

Biswas A, Bruder D, Wolf SA, Jeron A, Mack M, Heimesaat MM, Dunay IR (2015) Ly6C (high) monocytes control cerebral toxoplasmosis. J Immunol 194(7):3223–3235. https://doi.org/10.4049/jimmunol.1402037CrossRefPubMed

Biswas A, Bruder D, Wolf SA, Jeron A, Mack M, Heimesaat MM, Dunay IR (2017) Behavior of neutrophil granulocytes during Toxoplasma gondii infection in the central nervous system. Front Cell Infect Microbiol 7:259. https://doi.org/10.3389/fcimb.2017.00259CrossRefPubMedPubMedCentral

Bolton DJ, Robertson LJ (2016) Mental health disorders associated with foodborne pathogens. J Food Prot 79(11):2005–2017. https://doi.org/10.4315/0362-028x.Jfp-15-587CrossRefPubMed

Brooks JM, Carrillo GL, Su J, Lindsay DS, Fox MA, Blader I (2015) Toxoplasma gondii infections alter GABAergic synapses and signaling in the central nervous system. mBio 6(6), e01428–01415. https://doi.org/10.1128/mBio.01428-15

Butcher BA, Kim L, Johnson PF, Denkers EY (2001) Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-kappa B. J Immunol 167(4):2193–2201. https://doi.org/10.4049/jimmunol.167.4.2193CrossRefPubMed

Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Trendelenburg U (1994) International union of pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46(2):121–136PubMed

Cáceda R (2014) Suicidal behavior: risk and protective factors. J Revista De Neuro-Psiquiatría 77(1):3–18CrossRef

Campos AC, Vaz GN, Saito VM, Teixeira AL (2014) Further evidence for the role of interferon-gamma on anxiety-and depressive-like behaviors: involvement of hippocampal neurogenesis and NGF production. Neurosci Lett 578:100–105. https://doi.org/10.1016/j.neulet.2014.06.039CrossRefPubMed

Capuron L, Miller AH (2011) Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 130(2):226–238. https://doi.org/10.1016/j.pharmthera.2011.01.014CrossRefPubMedPubMedCentral

Capuron L, Schroecksnadel S, Féart C, Aubert A, Higueret D, Barberger-Gateau P, Layé S, Fuchs D (2011) Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. Biol Psychiatry 70(2):175–182. https://doi.org/10.1016/j.biopsych.2010.12.006CrossRefPubMed

Carruthers VB, Suzuki Y (2007) Effects of Toxoplasma gondii infection on the brain. Schizophr Bull 33(3):745–751. https://doi.org/10.1093/schbul/sbm008CrossRefPubMedPubMedCentral

Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, Taylor A, Poulton R (2002) Role of genotype in the cycle of violence in maltreated children. Science 297(5582):851–854. https://doi.org/10.1126/science.1072290CrossRefPubMed

Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, Taylor A, Poulton R (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301(5631):386–389. https://doi.org/10.1126/science.1083968CrossRefPubMed

Cerávolo IP, Chaves AC, Bonjardim CA, Sibley D, Romanha AJ, Gazzinelli RT (1999) Replication of Toxoplasma gondii, but not Trypanosoma cruzi, is regulated in human fibroblasts activated with gamma interferon: requirement of a functional JAK/STAT pathway. Infect Immun 67(5):2233–2240CrossRef

Choi DW (1994) Glutamate receptors and the induction of. J Neurosci 100:47. https://doi.org/10.2174/157015906776359540CrossRef

Ciranna L (2006) Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: implications in physiological functions and in pathology. Curr Neuropharmacol 4(2):101–114. https://doi.org/10.2174/157015906776359540CrossRefPubMedPubMedCentral

Condie BG, Bain G, Gottlieb DI, Capecchi MR (1997) Cleft palate in mice with a targeted mutation in the γ-aminobutyric acid-producing enzyme glutamic acid decarboxylase 67. Proc Natl Acad Sci 94(21):11451–11455. https://doi.org/10.1073/pnas.94.21.11451CrossRefPubMedPubMedCentral

Cooper JR, Bloom FE, Roth RH (2003) The biochemical basis of neuropharmacology. Oxford University Press, USA

Cotecchia S, Stanasila L, Diviani D (2012) Protein-protein interactions at the adrenergic receptors. Curr Drug Targets 13(1):15–27. https://doi.org/10.2174/138945012798868489CrossRefPubMedPubMedCentral

Courtet P, Jollant F, Buresi C, Castelnau D, Mouthon D, Malafosse A (2005) The monoamine oxidase A gene may influence the means used in suicide attempts. Psychiatr Genet 15(3):189–193. https://doi.org/10.1097/00041444-200509000-00009CrossRefPubMed

Courtois G, Gilmore TD (2006) Mutations in the NF-kappaB signaling pathway: implications for human disease. Oncogene 25(51):6831–6843. https://doi.org/10.1038/sj.onc.1209939CrossRefPubMed

Croarkin PE, Levinson AJ, Daskalakis ZJ (2011) Evidence for GABAergic inhibitory deficits in major depressive disorder. Neurosci Biobehav Rev 35(3):818–825. https://doi.org/10.1016/j.neubiorev.2010.10.002CrossRefPubMed

Curtis D, Watkins J (1960) The excitation and depression of spinal neurones by structurally related amino acids. J Neurochem 6(2):117–141. https://doi.org/10.1038/sj.onc.1209939CrossRefPubMed

Czarnewski P, Araujo ECB, Oliveira MC, Mineo TWP, Silva NM (2017) Recombinant TgHSP70 immunization protects against Toxoplasma gondii brain cyst formation by enhancing inducible nitric oxide expression. Front Cell Infect Microbiol 7:142. https://doi.org/10.3389/fcimb.2017.00142CrossRefPubMedPubMedCentral

da Silva RC, Langoni H (2009) Toxoplasma gondii: host-parasite interaction and behavior manipulation. J Parasitol 105(4):893–898. https://doi.org/10.1007/s00436-009-1526-6CrossRef

Daikhin Y, Yudkoff M (2000) Compartmentation of brain glutamate metabolism in neurons and glia. J Nutr 130(4S Suppl):1026s–1031s. https://doi.org/10.1093/jn/130.4.1026SCrossRefPubMed

Dalimi A, Abdoli A (2012) Latent toxoplasmosis and human. Iran J Parasitol 7(1):1PubMedPubMedCentral

Dard C, Sebastien Bailly S, Pepin JL, Brenier-Pinchart MP, Fricker-Hidalgo H, Peeters M, PellouxID H, Tamisier R (2020) Chronic toxoplasmosis and sleepiness in obstructive sleep apnea: Is there a link? PLoS ONE 15(7):e0235463. https://doi.org/10.1371/journal.pone.0235463CrossRefPubMedPubMedCentral

Dauvermann MR, Lee G, Dawson N (2017) Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research. Br J Pharmacol 174(19):3136–3160. https://doi.org/10.1111/bph.13919CrossRefPubMedPubMedCentral

David CN, Frias ES, Szu JI, Vieira PA, Hubbard JA, Lovelace J, Michael M, Worth D, McGovern KE, Ethell IM, Stanley BG, Korzus E, Fiacco TA, BinderDK, Wilson EH (2016) GLT-1-dependent disruption of CNS glutamate homeostasis and neuronal function by the protozoan parasite Toxoplasma gondii. PLoS Pathog 12(6):e1005643. https://doi.org/10.1371/journal.ppat.1005643

Davis KL, Kahn RS, Ko G, Davidson M (1991) Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148(11):1474–1486. https://doi.org/10.1176/ajp.148.11.1474CrossRefPubMed

de Barros J, Barbosa IG, Salem H, Rocha NP, Kummer A, Okusaga OO, Soares JC, Teixeira AL (2017) Is there any association between Toxoplasma gondii infection and bipolar disorder? a systematic review and meta-analysis. J Affect Disord 209:59–65. https://doi.org/10.1016/j.jad.2016.11.016CrossRefPubMed

Denkers EY, Gazzinelli RT (1998) Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 11(4):569–588. https://doi.org/10.1128/cmr.11.4.569CrossRefPubMedPubMedCentral

Diamond A, Briand L, Fossella J, Gehlbach L (2004) Genetic and neurochemical modulation of prefrontal cognitive functions in children. Am J Psychiatry 161(1):125–132. https://doi.org/10.1176/appi.ajp.161.1.125CrossRefPubMed

Dincel GC, Atmaca HT (2015) Nitric oxide production increases during Toxoplasma gondii encephalitis in mice. Exp Parasitol 156:104–112. https://doi.org/10.1016/j.exppara.2015.06.009CrossRefPubMed

Dubey JP (1998) Advances in the life cycle of Toxoplasma gondii. Int J Parasitol 28(7):1019–1024. https://doi.org/10.1016/s0020-7519(98)00023-xCrossRefPubMed

Dubey JP, Beattie CP (1988) Toxoplasmosis of animals and man. CRC Press Inc

Dunn AJ, Wang J (1995) Cytokine effects on CNS biogenic amines. NeuroImmunoModulation 2(6):319–328. https://doi.org/10.1159/000097211CrossRefPubMed

Dupont CD, Christian DA, Hunter CA (2012) Immune response and immunopathology during toxoplasmosis. Semin Immunopathol 34(6):793–813. https://doi.org/10.1007/s00281-012-0339-3CrossRefPubMedPubMedCentral

Durk T, Panther E, Muller T, Sorichter S, Ferrari D, Pizzirani C, Di Virgilio F, Myrtek D, Norgauer J, Idzko M (2005) 5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes. Int Immunol 17(5):599–606. https://doi.org/10.1093/intimm/dxh242CrossRefPubMed

Easton A, Sankaranarayanan S, Tanghe A, Terwel D, Lin AX, Hoque N, Bourin C, Gu H, Ahlijanian M, Bristow L (2013) Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer’s disease. J Psychopharmacol 230(2):279–289. https://doi.org/10.1007/s00213-013-3152-3CrossRef

Egan CE, Sukhumavasi W, Butcher BA, Denkers EY (2009) Functional aspects of Toll-like receptor/MyD88 signalling during protozoan infection: focus on Toxoplasma gondii. Clin Exp Immunol 156:17–24. https://doi.org/10.1111/j.1365-2249.2009.03876.xCrossRefPubMedPubMedCentral

Egashira T (1976) Studies on monoamine oxidase. XVIII. Enzymic properties of placental monoamine oxidase. Jpn. J. Pharmacol. 26(4), 493–500. https://doi.org/10.1254/jjp.26.493

Elsheikha HM, Zhu XQ (2016) Toxoplasma gondii infection and schizophrenia: an inter-kingdom communication perspective. Curr Opin Infect Dis 29(3):311–318. https://doi.org/10.1097/qco.0000000000000265CrossRefPubMed

Erdmann J, Stark K, Esslinger UB, Rumpf PM, Koesling D, De Wit C, Kaiser FJ, Braunholz D, Medack A, Fischer M (2013) Dysfunctional nitric oxide signalling increases risk of myocardial infarction. Nature 504(7480):432–436. https://doi.org/10.1038/nature12722CrossRefPubMed

Erhardt S, Blennow K, Nordin C, Skogh E, Lindstrom LH, Engberg G (2001a) Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci Lett 313(1–2):96–98. https://doi.org/10.1016/s0304-3940(01)02242-xCrossRefPubMed

Erhardt S, Blennow K, Nordin C, Skogh E, Lindström LH, Engberg G (2001b) Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci Lett 313(1–2):96–98. https://doi.org/10.1016/s0304-3940(01)02242-xCrossRefPubMed

Erhardt S, Lim CK, Linderholm KR, Janelidze S, Samuelsson M, Lundberg K, Postolache TT, Braunholz D, Träskman-Bendz L, Guillemin JG, Brundin L (2013) Connecting inflammation with glutamate agonism in suicidality. Neuropsychopharmacology 38(5):743–752. https://doi.org/10.1038/npp.2012.248CrossRefPubMedPubMedCentral

Fabiani S, Pinto B, Bruschi F (2013) Toxoplasmosis and neuropsychiatric diseases: can serological studies establish a clear relationship? Neurol Sci 34(4):417–425. https://doi.org/10.1007/s10072-012-1197-4CrossRefPubMed

Fekadu A, Shibre T, Cleare AJ (2010) Toxoplasmosis as a cause for behaviour disorders--overview of evidence and mechanisms. Folia Parasitol 57(2), 105–113. https://doi.org/10.14411/fp.2010.013

Feldman RS, Meyer JS, Quenzer LF, Cooper JR (1997) Principles of neuropsychopharmacology. Sinauer Associates Sunderland, MA

Fernandes Azevedo B, Barros Furieri L, Pecanha FM, Wiggers GA, Frizera Vassallo P, Ronacher Simoes M, Fiorim J, Rossi de Batista P, Fioresi M, Rossoni L, Stefanon I, Alonso MJ, Salaices M, Valentim Vassallo D (2012) Toxic effects of mercury on the cardiovascular and central nervous systems. J Biomed Sci 2012:949048. https://doi.org/10.1155/2012/949048CrossRef

Flegr J (2015) Neurological and neuropsychiatric consequences of chronic Toxoplasma infection. Curr Clin Microbiol Rep 2(4):163–172CrossRef

Flegr J, Kuba R (2016) The relation of Toxoplasma infection and sexual attraction to fear, danger, pain, and submissiveness. Evol Psychol 14(3):1474704916659746CrossRef

Flegr J, Klapilova K, Kankova S (2014) Toxoplasmosis can be a sexually transmitted infection with serious clinical consequences. Not all routes of infection are created equal. Med Hypotheses 83(3), 286–289. https://doi.org/10.1016/j.mehy.2014.05.019

Flegr J, Prandota J, Sovickova M, Israili ZH (2014) Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One 9(3), e90203. https://doi.org/10.1371/journal.pone.0090203

Frimpter GW, Andelman RJ, George WF (1969) Vitamin B6-dependency syndromes: new horizons in nutrition. Am J Clin Nutr 22(6):794–805. https://doi.org/10.1093/ajcn/22.6.794CrossRefPubMed

Fuglewicz AJ, Piotrowski P, Stodolak A (2017) Relationship between toxoplasmosis and schizophrenia: a review. Adv Clin Exp Med 26(6), 1031–1036. https://doi.org/10.17219/acem/61435

Fujigaki S, Saito K, Takemura M, Maekawa N, Yamada Y, Wada H, Seishima M (2002) L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase. Infect Immun 70(2):779–786. https://doi.org/10.1128/iai.70.2.779-786.2002CrossRefPubMedPubMedCentral

Fujigaki S, Takemura M, Hamakawa H, Seishima M, Saito K (2003) The mechanism of interferon-gamma induced anti Toxoplasma gondii by indoleamine 2,3-dioxygenase and/or inducible nitric oxide synthase vary among tissues. Adv Exp Med Biol 527:97–103. https://doi.org/10.1007/978-1-4615-0135-0_11CrossRefPubMed

Fuks JM, Arrighi RB, Weidner JM, Mendu SK, Jin Z, Wallin RP, Rethi B, Birnir B, Barragan A (2012) GABAergic signaling is linked to a hypermigratory phenotype in dendritic cells infected by Toxoplasma gondii. PLoS pathogens 8(12). https://doi.org/10.1371/journal.ppat.1003051

Furtado JM, Smith JR, Belfort R Jr, Gattey D, Winthrop KL (2011) Toxoplasmosis: a global threat. J Glob Infect Dis 3(3):281–284. https://doi.org/10.4103/0974-777x.83536CrossRefPubMedPubMedCentral

Galvan-Ramirez Mde L, Gutierrez-Maldonado A, Verduzco-Grijalva F, Jimenez JM (2014) The role of hormones on Toxoplasma gondii infection: a systematic review. Front Microbiol 5:503. https://doi.org/10.3389/fmicb.2014.00503CrossRefPubMed

Garry PS, Ezra M, Rowland MJ, Westbrook J, Pattinson KT (2015) The role of the nitric oxide pathway in brain injury and its treatment–from bench to bedside. Exp Neurol 263:235–243. https://doi.org/10.1016/j.expneurol.2014.10.017CrossRefPubMed

Gaskell EA, Smith JE, Pinney JW, Westhead DR, McConkey GA (2009) A unique dual activity amino acid hydroxylase in Toxoplasma gondii. PLoS ONE 4(3):e4801. https://doi.org/10.1371/journal.pone.0004801CrossRefPubMedPubMedCentral

Gaspar P, Cases O, Maroteaux L (2003) The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 4(12):1002–1012. https://doi.org/10.1038/nrn1256CrossRefPubMed

Gatkowska J, Wieczorek M, Dziadek B, Dzitko K, Dlugonska H (2012) Behavioral changes in mice caused by Toxoplasma gondii invasion of brain. Parasitol Res 111(1):53–58. https://doi.org/10.1007/s00436-011-2800-yCrossRefPubMedPubMedCentral

Gatkowska J, Wieczorek M, Dziadek B, Dzitko K, Dlugonska H (2013) Sex-dependent neurotransmitter level changes in brains of Toxoplasma gondii infected mice. Exp Parasitol 133(1):1–7. https://doi.org/10.1016/j.exppara.2012.10.005CrossRefPubMed

Giacobini E (1996) New trends in cholinergic therapy for Alzheimer disease: nicotinic agonists or cholinesterase inhibitors? Prog Brain Res 109:311–323. https://doi.org/10.1016/s0079-6123(08)62114-7CrossRefPubMed

Goff DC (2015) Drug development in schizophrenia: are glutamatergic targets still worth aiming at? Curr Opin Psychiatry 28(3):207–215. https://doi.org/10.1097/yco.0000000000000152CrossRefPubMed

Gohardehi S, Sharif M, Sarvi S, Moosazadeh M, Alizadeh-Navaei R, Hosseini SA, Amouei A, Pagheh A, Sadeghi M, Daryani A (2018) The potential risk of toxoplasmosis for traffic accidents: a systematic review and meta-analysis. Exp Parasitol 191:19–24. https://doi.org/10.1016/j.exppara.2018.06.003CrossRefPubMed

Gonzalez LE, Rojnik B, Urrea F, Urdaneta H, Petrosino P, Colasante C, Pino S, Hernandez L (2007) Toxoplasma gondii infection lower anxiety as measured in the plus-maze and social interaction tests in rats A behavioral analysis. Behav Brain Res 177(1):70–79. https://doi.org/10.1016/j.bbr.2006.11.012CrossRefPubMed

Goodwin D, Hrubec TC, Klein BG, Strobl JS, Werre SR, Han Q, Zajac AM, Lindsay DS (2012) Congenital infection of mice with Toxoplasma gondii induces minimal change in behavior and no change in neurotransmitter concentrations. J Parasitol 98(4):706–712. https://doi.org/10.1645/ge-3068.1CrossRefPubMed

Graeff FG, Viana MB, Mora PO (1997) Dual role of 5-HT in defense and anxiety. Neurosci Biobehav Rev 21(6):791–799. https://doi.org/10.1016/s0149-7634(96)00059-0CrossRefPubMed

Grimsby J, Lan NC, Neve R, Chen K, Shih JC (1990) Tissue distribution of human monoamine oxidase A and B mRNA. J Neurochem 55(4):1166–1169. https://doi.org/10.1111/j.1471-4159.1990.tb03121.xCrossRefPubMed

Grimsby J, Chen K, Wang L-J, Lan NC, Shih JC (1991) Human monoamine oxidase A and B genes exhibit identical exon-intron organization. Proc Natl Acad Sci 88(9):3637–3641CrossRef

Guidetti P, Bates GP, Graham RK, Hayden MR, Leavitt BR, MacDonald ME, Slow EJ, Wheeler VC, Woodman B, Schwarcz R (2006) Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice. Neurobiol Dis 23(1):190–197. https://doi.org/10.1016/j.nbd.2006.02.011CrossRefPubMed

Guillemin GJ, Smythe G, Takikawa O, Brew BJ (2005) Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia 49(1):15–23. https://doi.org/10.1002/glia.20090CrossRefPubMed

Gulaj E, Pawlak K, Bien B, Pawlak D (2010) Kynurenine and its metabolites in Alzheimer’s disease patients. Adv Med Sci 55(2):204–211. https://doi.org/10.2478/v10039-010-0023-6CrossRefPubMed

Hamie M, Najm R, Deleuze-Masquefa C, Antoine Bonnet P, Dubremetz JF, El Sabban M, El Hajj H (2021) Imiquimod targets toxoplasmosis through modulating host Toll-like receptor-MyD88 signaling. Front Immunol 12:629917. https://doi.org/10.3389/fimmu.2021.629917CrossRefPubMedPubMedCentral

Hamon M, Blier P (2013) Monoamine neurocircuitry in depression and strategies for new treatments. Prog Neuropsychopharmacol Biol Psychiatry 45:54–63. https://doi.org/10.1016/j.pnpbp.2013.04.009CrossRefPubMed

Hari Dass SA, Vyas A (2014) Toxoplasma gondii infection reduces predator aversion in rats through epigenetic modulation in the host medial amygdala. Mol Ecol 23(24):6114–6122CrossRef

Haroon E, Raison CL, Miller AH (2012) Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37(1):137–162. https://doi.org/10.1038/npp.2011.205CrossRefPubMed

Hayashi T (1952) A physiological study of epileptic seizures following cortical stimulation in animals and its application to human clinics. Jpn J Physiol 3:46–64. https://doi.org/10.2170/jjphysiol.3.46CrossRefPubMed

Henriquez SA, Brett R, Alexander J, Pratt J, Roberts CW (2009) Neuropsychiatric disease and Toxoplasma gondii infection. NeuroImmunoModulation 16(2):122–133. https://doi.org/10.1159/000180267CrossRefPubMed

Herlenius E, Lagercrantz H (2004) Development of neurotransmitter systems during critical periods. Exp Neurol 190:8–21. https://doi.org/10.1016/j.expneurol.2004.03.027CrossRef

Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX (2001) The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non-α7 nicotinic receptor expression: physiopathological implications. J Neurosci 21(19):7463–7473. https://doi.org/10.1523/JNEUROSCI.21-19-07463.2001CrossRefPubMedPubMedCentral

Hinze-Selch D (2015) Toxoplasma gondii infection and neuropsychiatric disease: current insight. Reports Parasitol 4:43–51. https://doi.org/10.2147/RIP.S52980CrossRef

Hofmann S, Philbrook C, Gerbitz K-D, Bauer MF (2003) Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product. Hum Mol Genet 12(16):2003–2012. https://doi.org/10.1093/hmg/ddg214CrossRefPubMed

Hohmann CF (2003) A morphogenetic role for acetylcholine in mouse cerebral neocortex. Neurosci Biobehav Rev 27(4):351–363. https://doi.org/10.1016/s0149-7634(03)00066-6CrossRefPubMed

Houser C, Crawford G, Salvaterra P, Vaughn J (1985) Immunocytochemical localization of choline acetyltransferase in rat cerebral cortex: a study of cholinergic neurons and synapses. J Comp Neurol 234(1):17–34. https://doi.org/10.1002/cne.902340103CrossRefPubMed

Hsu YPP, Weyler W, Chen S, Sims KB, Rinehart WB, Utterback MC, Powell JF, Breakefield XO (1988) Structural features of human monoamine oxidase A elucidated from cDNA and peptide sequences. J Neurochem 51(4):1321–1324. https://doi.org/10.1111/j.1471-4159.1988.tb03105.xCrossRefPubMed

Hsu PC, Groer M, Beckie T (2014) New findings: depression, suicide, and Toxoplasma gondii infection. J Am Assoc Nurse Pract 26(11):629–637. https://doi.org/10.1002/2327-6924.12129CrossRefPubMed

Hull EM, Du J, Lorrain DS, Matuszewich L (1995) Extracellular dopamine in the medial preoptic area: implications for sexual motivation and hormonal control of copulation. J Neurosci 15(11):7465–7471CrossRef

Hull EM, Muschamp JW, Sato S (2004) Dopamine and serotonin: influences on male sexual behavior. Physiol Behav 83(2):291–307. https://doi.org/10.1016/j.physbeh.2004.08.018CrossRefPubMed

Hunter CA, Candolfi E, Subauste C, Van Cleave V, Remington JS (1995) Studies on the role of interleukin-12 in acute murine toxoplasmosis. Immunology 84(1):16–20PubMedPubMedCentral

Hunter C, Suzuki Y, Subauste C, Remington J (1996) Cells and cytokines in resistance to Toxoplasma gondii, Toxoplasma gondii. Springer 113–125.

Hurley RA, Taber KH (2012) Latent Toxoplasma gondii: emerging evidence for influences on neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci 24(4):376–383. https://doi.org/10.1176/appi.neuropsych.12100234CrossRefPubMed

Ihara F, Nishimura M, Muroi Y, Mahmoud ME, Yokoyama N, Nagamune K, Nishikawa Y (2016) Toxoplasma gondii infection in mice impairs long-term fear memory consolidation through dysfunction of the cortex and amygdala. Infect Immun 84(10):2861–2870. https://doi.org/10.1128/iai.00217-16CrossRefPubMedPubMedCentral

Javitt DC (2014) Current and emergent treatments for symptoms and neurocognitive impairment in schizophrenia. Curr Treat Options Psychiatry 1(2):107–120. https://doi.org/10.1007/s40501-014-0010-9CrossRefPubMedCentral

Johnston MV, Silverstein FS (2003) The newborn brain: neuroscience and clinical applications. Cambridge University Press115

Jones JL, Lopez A, Wilson M (2003) Congenital Toxoplasmosis. Am Fam Physician 67(10):2131–2138

Jun CD, Kim SH, Soh CT, Kang SS, Chung HT (1993) Nitric oxide mediates the toxoplasmastatic activity of murine microglial cells in vitro. Immunol Invest 22(8):487–501. https://doi.org/10.3109/08820139309084178CrossRefPubMed

Kalueff AV, Nutt DJ (2007) Role of GABA in anxiety and depression. J Depress Anxiety 24(7):495–517. https://doi.org/10.1002/da.20262CrossRef

Kannan G, Crawford JA, Yang C, Gressitt KL, Ihenatu C, Krasnova IN, Cadet JL, Yolken RH, Severance EG, Pletnikov MV (2016) Anti-NMDA receptor autoantibodies and associated neurobehavioral pathology in mice are dependent on age of first exposure to Toxoplasma gondii. Neurobiol Dis 91:307–314. https://doi.org/10.1016/j.nbd.2016.03.005CrossRefPubMedPubMedCentral

Kannan G, Gressitt K, Yang S, Stallings C, Katsafanas E, Schweinfurth L, Savage C, Adamos M, Sweeney K, Origoni A (2017) Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia. Transl Psychiatry 7(8):e1186–e1186. https://doi.org/10.1038/tp.2017.162CrossRefPubMedPubMedCentral

Karolewicz B, Maciag D, O’Dwyer G, Stockmeier CA, Feyissa AM, Rajkowska G (2010) Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression. Int J Neuropsychopharmacol 13(4):411–420. https://doi.org/10.1017/S1461145709990587CrossRefPubMed

Kegel ME, Bhat M, Skogh E, Samuelsson M, Lundberg K, Dahl ML, Sellgren C, Schwieler L, Engberg G, Schuppe-Koistinen I, Erhardt S (2014) Imbalanced kynurenine pathway in schizophrenia. Int J Tryptophan Res 7:15–22. https://doi.org/10.4137/ijtr.S16800CrossRefPubMedPubMedCentral

Khan IA, Schwartzman JD, Matsuura T, Kasper LH (1997) A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proc Natl Acad Sci USA 94(25):13955–13960. https://doi.org/10.1073/pnas.94.25.13955CrossRefPubMedPubMedCentral

Khan IA, MacLean JA, Lee FS, Casciotti L, DeHaan E, Schwartzman JD, Luster AD (2000) IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 12(5):483–494. https://doi.org/10.1016/s1074-7613(00)80200-9CrossRefPubMed

King MD, Lindsay DS, Holladay S, Ehrich M (2003) Neurotoxicity and immunotoxicity assessment in CBA/J mice with chronic Toxoplasma gondii infection and single-dose exposure to methylmercury. Int J Toxicol 22(1):53–61. https://doi.org/10.1080/10915810305075CrossRefPubMed

Kitagami T, Yamada K, Miura H, Hashimoto R, Nabeshima T, Ohta T (2003) Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats: role of nitric oxide as a signal crossing the blood-brain barrier. Brain Res 978(1–2):104–114. https://doi.org/10.1016/s0006-8993(03)02776-8CrossRefPubMed

Klaren VN, Kijlstra A (2002) Toxoplasmosis, an overview with emphasis on ocular involvement. Ocul Immunol Inflamm 10(1):1–26. https://doi.org/10.1076/ocii.10.1.1.10330CrossRefPubMed

Klein SL (2003) Parasite manipulation of the proximate mechanisms that mediate social behavior in vertebrates. Physiol Behav 79(3):441–449. https://doi.org/10.1016/s0031-9384(03)00163-xCrossRefPubMed

Koblansky AA, Jankovic D, Oh H, Hieny S, Sungnak W, Mathur R, Hayden MS, Akira S, Sher A, Ghosh S (2013) Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii. Immunity 38:119–130. https://doi.org/10.1016/j.immuni.2012.09.016CrossRefPubMed

Kõks S, Planken A, Luuk H, Vasar E (2002) Cat odour exposure increases the expression of wolframin gene in the amygdaloid area of rat. Neurosci Lett 322(2):116–120. https://doi.org/10.1016/s0304-3940(02)00110-6CrossRefPubMed

Konradt C, Ueno N, Christian DA, Delong JH, Pritchard GH, Herz J, Bzik DJ, Koshy AA, McGavern DB, Lodoen MB, Hunter CA (2016) Endothelial cells are a replicative niche for entry of Toxoplasma gondii to the central nervous system. Nat Microbiol 1:16001. https://doi.org/10.1038/nmicrobiol.2016.1CrossRefPubMedPubMedCentral

Kucera K, Koblansky AA, Saunders LP, Frederick KB, De La Cruz EM, Ghosh S, Modisa Y (2010) Structure-based analysis of Toxoplasma gondii profilin: a parasitespecific motif is required for recognition by Toll-like receptor 11. J Mol Biol 403:616–629. https://doi.org/10.1016/j.jmb.2010.09.022CrossRefPubMedPubMedCentral

Kusbeci OY, Miman O, Yaman M, Aktepe OC, Yazar S (2011) Could Toxoplasma gondii have any role in Alzheimer disease? Alzheimers Dis Assoc Disord 25:1–3. https://doi.org/10.1097/WAD.0b013e3181f73bc2CrossRef

Lamadrid-Romero M, Solís KH, Cruz-Reséndiz MS, Pérez JE, Díaz NF, Flores-Herrera H, García-López G, Perichart O, Reyes-Munoz E, Arenas-Huertero F, Eguía-Aguilar P, Molina-Hernández A (2018) Central nervous system development-related microRNAs levels increase in the serum of gestational diabetic women during the first trimester of pregnancy. Neurosci Res 130:8–22. https://doi.org/10.1016/j.neures.2017.08.003CrossRefPubMed

Lang D, Schott BH, van Ham M, Morton L, Kulikovskaja L, Herrera-Molina R, Pielot R, Klawonn F, Montag D, Jänsch L (2018) Chronic Toxoplasma infection is associated with distinct alterations in the synaptic protein composition. J Neuroinflammation 15(1):216. https://doi.org/10.1186/s12974-018-1242-1CrossRefPubMedPubMedCentral

Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D’Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB (1996) Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93(17):9235–9240. https://doi.org/10.1073/pnas.93.17.9235CrossRefPubMedPubMedCentral

Lau JY, Goldman D, Buzas B, Fromm SJ, Guyer AE, Hodgkinson C, Monk CS, Nelson EE, Shen PH, Pine DS, Ernst M (2009) Amygdala function and 5-HTT gene variants in adolescent anxiety and major depressive disorder. Biol Psychiatry 65(4):349–355. https://doi.org/10.1016/j.biopsych.2008.08.037CrossRefPubMed

Lavoie A, Twyman R (1996) Direct evidence for diazepam modulation of GABAA receptor microscopic affinity. Neuropharmacology 35(9–10):1383–1392. https://doi.org/10.1016/s0028-3908(96)00077-9CrossRefPubMed

Leite AZ, Rodrigues NC, Gonzaga MI, Paiolo JCC, de Souza CA, Stefanutto NAV, Omori WP, Pinheiro DG, Brisotti JL, Matheucci Junior E, Mariano VS, de Oliveira GLV (2017) Detection of increased plasma interleukin-6 levels and prevalence of Prevotella copri and Bacteroides vulgatus in the feces of type 2 diabetes patients. Front Immunol 8:1107. https://doi.org/10.3389/fimmu.2017.01107CrossRefPubMedPubMedCentral

Lesch KP, Bengel., Heils A, Sabol S., Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer D H, Murphy DL, (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274(5292):1527–1531. https://doi.org/10.1126/science.274.5292.1527CrossRefPubMed

Levinson AJ, Fitzgerald PB, Favalli G, Blumberger DM, Daigle M, Daskalakis ZJ (2010) Evidence of cortical inhibitory deficits in major depressive disorder. Biol Psychiatry 67(5):458–464. https://doi.org/10.1016/j.neubiorev.2010.10.002CrossRefPubMed

Lewinsohn R, Glover V, Sandler M (1980) Development of benzylamine oxidase and monoamine oxidase A and B in man. Biochem Pharmacol 29(9):1221–1230. https://doi.org/10.1016/0006-2952(80)90278-6CrossRefPubMed

Li YE, Kannan G, Pletnikov MV, Yolken RH, Xiao J (2015) Chronic infection of Toxoplasma gondii downregulates miR-132 expression in multiple brain regions in a sex-dependent manner. Parasitology 142(4):623–632. https://doi.org/10.1017/s003118201400167xCrossRefPubMed

Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433(7027):769–773. https://doi.org/10.1038/nature03315CrossRefPubMed

Litteljohn D, Nelson E, Hayley S (2014) IFN-γ differentially modulates memory-related processes under basal and chronic stressor conditions. Front Cell Neurosci 8:391. https://doi.org/10.3389/fncel.2014.00391CrossRefPubMedPubMedCentral

Lucchese G (2017) From toxoplasmosis to schizophrenia via NMDA dysfunction: peptide overlap between Toxoplasma gondii and N-methyl-d-aspartate receptors as a potential mechanistic link. Front Psychiatry 8:37. https://doi.org/10.3389/fpsyt.2017.00037CrossRefPubMedPubMedCentral

MacRae JI, Sheiner L, Nahid A, Tonkin C, Striepen B, McConville MJ (2012) Mitochondrial metabolism of glucose and glutamine is required for intracellular growth of Toxoplasma gondii. Cell Host Microbe 12(5):682–692. https://doi.org/10.1016/j.chom.2012.09.013CrossRefPubMedPubMedCentral

Maggi L, Le Magueresse C, Changeux J-P, Cherubini E (2003) Nicotine activates immature “silent” connections in the developing hippocampus. J Proc Natl Acad Sci 100(4):2059–2064. https://doi.org/10.1073/pnas.0437947100CrossRef

Mahmoud ME, Ihara F, Fereig RM, Nishimura M, Nishikawa Y (2016) Induction of depression-related behaviors by reactivation of chronic Toxoplasma gondii infection in mice. Behav Brain Res 298(Pt B):125–133. https://doi.org/10.1016/j.bbr.2015.11.005CrossRefPubMed

Mahmoud M E, Fereig R, Nishikawa Y (2017) Involvement of host defense mechanisms against Toxoplasma gondii infection in anhedonic and despair-like behaviors in mice. Infect Immun 85(4). doi:https://doi.org/10.1128/iai.00007-17

Mahmoudvand H, Sheibani V, Keshavarz H, Shojaee S, Esmaeelpour K, Ziaali N (2016) Acetylcholinesterase inhibitor improves learning and memory impairment induced by Toxoplasma gondii infection. Iran J Parasitol 11(2):177PubMedPubMedCentral

Marín O, Rubenstein JL (2001) A long, remarkable journey: tangential migration in the telencephalon. Nat Rev Neurosci 2(11):780–790. https://doi.org/10.1038/35097509CrossRefPubMed

McConkey GA, Martin HL, Bristow GC, Webster JP (2013) Toxoplasma gondii infection and behaviour - location, location, location? J Exp Biol 216(Pt 1):113–119. https://doi.org/10.1242/jeb.074153CrossRefPubMedPubMedCentral

Melamede R (2009) Parasitic brain infection, endocannabinoids, and schizophrenia. Med Hypotheses 72(2):220–222. https://doi.org/10.1016/j.mehy.2008.08.025CrossRefPubMed

Meldrum BS (2000) Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 130(4):1007S-1015S. https://doi.org/10.1093/jn/130.4.1007SCrossRefPubMed

Mentzer A, Perry M, Fitzgerald N, Barrington S, Siddiqui A, Kulasegaram R (2012) Is it all cerebral toxoplasmosis? Lancet 379(9812):286. https://doi.org/10.1016/s0140-6736(11)61579-1CrossRefPubMed

Miller AH, Maletic V, Raison CL (2009a) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65(9):732–741CrossRef

Miller CM, Boulter NR, Ikin RJ, Smith NC (2009b) The immunobiology of the innate response to Toxoplasma gondii. Int J Parasitol 39(1):23–39. https://doi.org/10.1016/j.ijpara.2008.08.002CrossRefPubMed

Miller BH, Zeier Z, Xi L, Lanz TA, Deng S, Strathmann J, Willoughby D, Kenny PJ, Elsworth JD, Lawrence MS, Roth RH, Edbauer D, Kleiman RJ, Wahlestedt C (2012) MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc Natl Acad Sci USA 109(8):3125–3130. https://doi.org/10.1073/pnas.1113793109CrossRefPubMedPubMedCentral

Moghaddam B, Javitt D (2012) From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 37(1):4–15. https://doi.org/10.1038/npp.2011.181CrossRefPubMed

Mohle L, Parlog A, Pahnke J, Dunay IR (2014) Spinal cord pathology in chronic experimental Toxoplasma gondii infection. Eur J Immunol (bp) 4(1):65–75. https://doi.org/10.1556/EuJMI.4.2014.1.6CrossRef

Mohle L, Israel N, Paarmann K, Krohn M, Pietkiewicz S, Muller A, Lavrik IN, Buguliskis JS, Schott BH, Schluter D, Gundelfinger ED, Montag D, Seifert U, Pahnke J, Dunay IR (2016) Chronic Toxoplasma gondii infection enhances beta-amyloid phagocytosis and clearance by recruited monocytes. Acta Neuropathol Commun 4:25. https://doi.org/10.1186/s40478-016-0293-8CrossRefPubMedPubMedCentral

Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965–1975CrossRef

Mortensen PB, Norgaard-Pedersen B, Waltoft BL, Sorensen TL, Hougaard D, Yolken RH (2007) Early infections of Toxoplasma gondii and the later development of schizophrenia. Schizophr Bull 33(3):741–744. https://doi.org/10.1093/schbul/sbm009CrossRefPubMedPubMedCentral

Müller N, Schwarz M (2007) The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J Neural Transm 269-80.https://doi.org/10.1007/978-3-211-73574-9_33

Muller N, Schwarz M (2006) Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotox Res 10(2):131–148. https://doi.org/10.1007/bf03033242CrossRefPubMed

Munoz M, Liesenfeld O, Heimesaat MM (2011) Immunology of Toxoplasma gondii. J Immunol Rev 240(1):269–285. https://doi.org/10.1111/j.1600-065X.2010.00992.xCrossRef

Murakami Y, Hoshi M, Hara A, Takemura M, Arioka Y, Yamamoto Y, Matsunami H, Funato T, Seishima M, Saito K (2012) Inhibition of increased indoleamine 2,3-dioxygenase activity attenuates Toxoplasma gondii replication in the lung during acute infection. Cytokine 59(2):245–251. https://doi.org/10.1016/j.cyto.2012.04.022CrossRefPubMed

Murphy DL, Garrick NA, Aulakh CS, Cohen RM (1984) New contributions for basic science to understanding the effects of monoamine oxidase inhibiting antidepressants. J Clin Psychiatry 45:37–43PubMed

Mustafa AK, Gadalla MM, Snyder SH (2009) Signaling by gasotransmitters. J Sci Signal 2(68), re2-re2. https://doi.org/10.1126/scisignal.268re2

Nakamura T, Sato A, Kitsukawa T, Momiyama T, Yamamori T, Sasaoka T (2014) Distinct motor impairments of dopamine D1 and D2 receptor knockout mice revealed by three types of motor behavior. Front Integr Neurosci 8:56. https://doi.org/10.3389/fnint.2014.00056CrossRefPubMedPubMedCentral

Nath A, Hobson DE, Russel A (1993) Movement disorders with cerebral toxoplasmosis and AIDS. Mov Disord 8(1):107–112. https://doi.org/10.1002/mds.870080119CrossRefPubMed

Nayeri T, Sarvi S, Moosazadeh M, Hosseininejad Z, Sharif M, Amouei A, Daryani A (2020b) Relationship between toxoplasmosis and autism: a systematic review and meta-analysis. Microb Pathog 147:104434. https://doi.org/10.1016/j.micpath.2020.104434

Nayeri T, Sarvi S, Moosazadeh M, Hosseininejad Z, Sharif M, Amouei A, Daryani A (2020c) Association between Toxoplasma gondii infection and headache: a systematic review and meta-analysis. Infect Disord Drug Targets 20:1–8. https://doi.org/10.2174/1871526520666200617135851

Nayeri Chegeni T, Sarvi S, Amouei MM, Hosseininejad Z, Aghayan S, Daryani A (2019b) Relationship between toxoplasmosis and obsessive compulsive disorder: a systematic review and meta-analysis. PLOS Negl Trop Dis 13(4):e0007306. https://doi.org/10.1371/journal.pntd.0007306

Nayeri Chegeni T, Sarvi S, Moosazadeh M, Sharif M, Aghayan SA, Amouei A, Hosseininejad Z, Daryani A (2019c) Is Toxoplasma gondii a potential risk factor for Alzheimer’s disease? a systematic review and meta-analysis. Microb Pathog 137:103751. https://doi.org/10.1016/j.micpath.2019.103751

Nayeri Chegeni T, Sharif M, Sarvi S, Moosazadeh M, Montazeri M, Aghayan SA, Balalami NJ, Gholami S, Hosseininejad Z, Saberi R, Anvari D, Gohardehi S, Daryani A (2019a) Is there any association between Toxoplasma gondii infection and depression? a systematic review and meta-analysis. PLoS ONE 14(6):e0218524. https://doi.org/10.1371/journal.pone.0218524

Nayeri T, Sarvi S, Moosazadeh M, Hosseininejad Z, Amouei A, Daryani A (2020a) Toxoplasma gondii infection and risk of attention-deficit hyperactivity disorder: a systematic review and meta-analysis. Pathog Glob Health 1-10.https://doi.org/10.1080/20477724.2020.1738153

Neurauter G, Schrocksnadel K, Scholl-Burgi S, Sperner-Unterweger B, Schubert C, Ledochowski M, Fuchs D (2008) Chronic immune stimulation correlates with reduced phenylalanine turnover. Curr Drug Metab 9(7):622–627. https://doi.org/10.2174/138920008785821738CrossRefPubMed

Ngô HM, Zhou Y, Lorenzi H, Wang K, Kim T-K, Zhou Y, El Bissati K, Mui E, Fraczek L, Rajagopala SV (2017) Toxoplasma modulates signature pathways of human epilepsy, neurodegeneration & cancer. Sci Rep 7(1):11496. https://doi.org/10.1038/s41598-017-10675-6CrossRefPubMedPubMedCentral

Ngoungou EB, Bhalla D, Nzoghe A, Darde ML, Preux PM (2015) Toxoplasmosis and epilepsy–systematic review and meta analysis. PLOS Negl Trop Dis 9(2):e0003525. https://doi.org/10.1371/journal.pntd.0003525CrossRefPubMedPubMedCentral

Nilsson L, Linderholm K, Engberg G, Paulson L, Blennow K, Lindström L, Nordin C, Karanti A, Persson P, Erhardt S (2005) Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia. J Schizophr Res 80(2–3):315–322. https://doi.org/10.1016/j.biopsych.2005.06.024CrossRef

Nilsson KW, Sjoberg RL, Damberg M, Leppert OJ, Alm PO, Lindstrom L, Oreland L (2006) Role of monoamine oxidase A genotype and psychosocial factors in male adolescent criminal activity. Biol Psychiatry 59(2):121–127. https://doi.org/10.1016/j.biopsych.2005.06.024CrossRefPubMed

Nilsson KW, Wargelius HL, Sjoberg RL, Leppert J, Oreland L (2008) The MAO-A gene, platelet MAO-B activity and psychosocial environment in adolescent female alcohol-related problem behaviour. Drug Alcohol Depend 93(1–2):51–62. https://doi.org/10.1016/j.drugalcdep.2007.08.022CrossRefPubMed

Notarangelo FM, Wilson EH, Horning KJ, Thomas MA, Harris TH, Fang Q, Hunter CA, Schwarcz R (2014) Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia. Schizophr Res 152(1):261–267. https://doi.org/10.1016/j.schres.2013.11.011CrossRefPubMed

Ohno Y (2011) Therapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinson’s disease. CNS Neurosci Ther 17(1):58–65. https://doi.org/10.1111/j.1755-5949.2010.00211.xCrossRefPubMed

Ordway GA, Widdowson PS, Smith KS, Halaris A (1994) Agonist binding to α2-adrenoceptors is elevated in the locus coeruleus from victims of suicide. J Neurochem 63(2):617–624. https://doi.org/10.1046/j.1471-4159.1994.63020617.xCrossRefPubMed

Ortiz PA, Garvin JL (2003) Cardiovascular and renal control in NOS-deficient mouse models. Am J Physiol Regul Integr Comp Physiol 284(3), R628–638. https://doi.org/10.1152/ajpregu.00401.2002

Oxenkrug G (2013) Serotonin-kynurenine hypothesis of depression: historical overview and recent developments. Curr Drug Targets 14(5):514–521. https://doi.org/10.2174/1389450111314050002CrossRefPubMedPubMedCentral

Palmer BS( 2007) Meta-analysis of three case controlled studies and an ecological study into the link between cryptogenic epilepsy and chronic toxoplasmosis infection. Seizure 16(8), 657–663. https://doi.org/10.1016/j.seizure.2007.05.010

Papouin T, Dunphy JM, Tolman M, Dineley KT, Haydon PG (2017) Septal cholinergic neuromodulation tunes the astrocyte-dependent gating of hippocampal NMDA receptors to wakefulness. Neuron 94(4), 840–854. e847. https://doi.org/10.1016/j.neuron.2017.04.021

Parlog A, Harsan LA, Zagrebelsky M, Weller M, von Elverfeldt D, Mawrin C, Korte M, Dunay IR (2014) Chronic murine toxoplasmosis is defined by subtle changes in neuronal connectivity. Dis Models Mech 7(4):459–469. https://doi.org/10.1242/dmm.014183CrossRef

Parlog A, Schluter D, Duna IR (2015) Toxoplasma gondii-induced neuronal alterations. Parasite Immunol 37(3):159–170. https://doi.org/10.1111/pim.12157CrossRefPubMed

Patri M (2019) Synaptic transmission and amino acid neurotransmitters. Neurochemical Basis of Brain Function and Dysfunction. IntechOpen.

Paul V, Ekambaram P (2011) Involvement of nitric oxide in learning & memory processes. Indian J Med Res 133:471–478PubMedPubMedCentral

Petitto JM, McCarthy DB, Rinker CM, Huang Z, Getty T (1997) Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2. J Neuroimmunol 73(1–2):183–190. https://doi.org/10.1016/s0165-5728(96)00196-8CrossRefPubMed

Pfefferkorn ER (1984) Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci USA 81(3):908–912. https://doi.org/10.1073/pnas.81.3.908CrossRefPubMedPubMedCentral

Plattner F, Yarovinsky F, Romero S, Didry D, Carlier MF, Sher A, Soldati-Favre D (2008) Toxoplasma profilin is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response. Cell Host Microbe 3:77–87. https://doi.org/10.1016/j.chom.2008.01.001CrossRefPubMed

Pliszka SR, Maas JW, Javors MA, Rogeness GA, Baker BS, J, (1994) Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 33(8):1165–1173. https://doi.org/10.1097/00004583-199410000-00012CrossRefPubMed

Prandovszky E, Gaskell E, Martin H, Dubey JP, Webster JP, McConkey GA (2011) The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS ONE 6(9):e23866. https://doi.org/10.1371/journal.pone.0023866CrossRefPubMedPubMedCentral

Prast H, Philippu A (2001) Nitric oxide as modulator of neuronal function. Prog Neurobiol 64(1):51–68. https://doi.org/10.1016/S0301-0082(00)00044-7CrossRefPubMed

Remenyi J, van den Bosch MW, Palygin O, Mistry RB, McKenzie C, Macdonald A, Hutvagner G, Arthur JS, Frenguelli BG, Pankratov Y (2013) miR-132/212 knockout mice reveal roles for these miRNAs in regulating cortical synaptic transmission and plasticity. PLoS ONE 8(4):e62509. https://doi.org/10.1371/journal.pone.0062509CrossRefPubMedPubMedCentral

Rommelfanger K, Edwards G, Freeman K, Liles L, Miller G, Weinshenker D (2007) Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice. Proc Natl Acad Sci 104(34):13804–13809. https://doi.org/10.1073/pnas.0702753104CrossRefPubMedPubMedCentral

Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Hoberg MD, Vidensky S, Chung DS (2005) β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433(7021):73–77. https://doi.org/10.1038/nature03180CrossRefPubMed

Rozenfeld C, Martinez R, Seabra S, Sant’anna C, Goncalves JG, Bozza M, Moura-Neto V, SouzaW De (2005) Toxoplasma gondii prevents neuron degeneration by interferon-gamma-activated microglia in a mechanism involving inhibition of inducible nitric oxide synthase and transforming growth factor-beta1 production by infected microglia. Am J Pathol 167(4):1021–1031. https://doi.org/10.1016/s0002-9440(10)61191-1CrossRefPubMedPubMedCentral

Sa Q, Tiwari A, Ochiai E, Mullins J, Suzuki Y (2018) Inducible nitric oxide synthase in innate immune cells is important for restricting cyst formation of Toxoplasma gondii in the brain but not required for the protective immune process to remove the cysts. Microbes Infect 20(4):261–266. https://doi.org/10.1016/j.micinf.2017.12.004CrossRefPubMed

Sadeghi M, Riahi SM, Mohammadi M, Saber V, Aghamolaie S, Moghaddam SA, Aghaei S, Javanian M, Gamble HR, Rostami A (2019) An updated meta-analysis of the association between Toxoplasma gondii infection and risk of epilepsy. Trans R Soc Trop Med Hyg 113(8):453–462. https://doi.org/10.1093/trstmh/trz025CrossRefPubMed

Saito K, Markey SP, Heyes MP (1992) Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Neuroscience 51(1):25–39. https://doi.org/10.1016/0306-4522(92)90467-gCrossRefPubMed

Sanecka A, Frickel EM (2012) Use and abuse of dendritic cells by Toxoplasma gondii. Virulence 3:678–689. https://doi.org/10.4161/viru.22833CrossRefPubMedPubMedCentral

Scanzano A, Cosentino M (2015) Adrenergic regulation of innate immunity: a review. Front Pharmacol 6:171. https://doi.org/10.3389/fphar.2015.00171CrossRefPubMedPubMedCentral

Scharton-Kersten TM, Yap G, Magram J, Sher A (1997) Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J Exp Med 185(7):1261–1274. https://doi.org/10.1084/jem.185.7.1261CrossRefPubMedPubMedCentral

Schwarcz R, Hunter CA (2007) Toxoplasma gondii and schizophrenia: linkage through astrocyte-derived kynurenic acid? Schizophr Bull 33(3):652–653. https://doi.org/10.1093/schbul/sbm030CrossRefPubMedPubMedCentral

Schwarcz R, Pellicciari R (2002) Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther 303(1):1–10. https://doi.org/10.1124/jpet.102.034439CrossRefPubMed

Schwarcz R, Rassoulpour A, Wu H-Q, Medoff D, Tamminga CA, Roberts RC (2001) Increased cortical kynurenate content in schizophrenia. Biol Psychiatry 50(7):521–530. https://doi.org/10.1016/s0006-3223(01)01078-2CrossRefPubMed

Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13(7):465–477. https://doi.org/10.1038/nrn3257CrossRefPubMedPubMedCentral

Shen J (2013) Modeling the glutamate–glutamine neurotransmitter cycle. Front Neuroenergetics 5:1–13. https://doi.org/10.3389/fnene.2013.00001CrossRefPubMedPubMedCentral

Sher A, Tosh K, Jankovic D (2017) Innate recognition of Toxoplasma gondii in humans involves a mechanism distinct from that utilized by rodents. Cell Mol Immunol 14:36–42. https://doi.org/10.1038/cmi.2016.12CrossRefPubMed

Sjoberg RL, Nilsson KW, Nordquist N, Ohrvik J, Leppert J, Lindstrom L, Oreland L (2006) Development of depression: sex and the interaction between environment and a promoter polymorphism of the serotonin transporter gene. Int J Neuropsychopharmacol 9(4):443–449. https://doi.org/10.1017/s1461145705005936CrossRefPubMed

Skallova A, Kodym P, Frynta D, Flegr J (2006) The role of dopamine in Toxoplasma-induced behavioural alterations in mice: an ethological and ethopharmacological study. Parasitology 133(Pt 5):525–535. https://doi.org/10.1017/s0031182006000886CrossRefPubMed

Sperner-Unterweger B, Kohl C, Fuchs D (2014) Immune changes and neurotransmitters: possible interactions in depression? Prog Neuropsychopharmacol Biol Psychiatry 48:268–276. https://doi.org/10.1016/j.pnpbp.2012.10.006CrossRefPubMed

Stein V, Nicoll RA (2003) GABA generates excitement. Neuron 37(3):375–378CrossRef

Steiner J, Walter M, Gos T, Guillemin GJ, Bernstein HG, Sarnyai Z, Mawrin C, Brisch R, Bielau H, Meyer zu Schwabedissen L, Bogerts B, Myint AM, (2011) Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? Neuroinflammation 8:94. https://doi.org/10.1186/1742-2094-8-94CrossRef

Steinert JR, Chernova T, Forsythe ID (2010) Nitric oxide signaling in brain function, dysfunction, and dementia. Neuroscientist 16(4):435–452. https://doi.org/10.1177/1073858410366481CrossRefPubMed

Stibbs HH (1985) Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann Trop Med Parasitol 79(2):153–157. https://doi.org/10.1080/00034983.1985.11811902CrossRefPubMed

Strobl JS, Goodwin DG, Rzigalinski BA, Lindsay DS (2012) Dopamine stimulates propagation of Toxoplasma gondii tachyzoites in human fibroblast and primary neonatal rat astrocyte cell cultures. J Parasitol 98(6):1296–1299. https://doi.org/10.1645/ge-2760.1CrossRefPubMed

Sugden K, Moffitt TE, Pinto L, Poulton R, Williams BS, Caspi A (2016) Is Toxoplasma gondii infection related to brain and behavior impairments in humans? Evidence from a population-representative birth cohort. PLoS ONE 11(2):e0148435. https://doi.org/10.1371/journal.pone.0148435CrossRefPubMedPubMedCentral

Sullivan JL, Cavenar J, Maltbie A, Lister P, Zung W (1979) Familial biochemical and clinical correlates of alcoholics with low platelet monoamine oxidase activity. Biol Psychiatry 14:385–394PubMed

Sundström E, Kölare S, Souverbic F, Samuelsson E-B, Pschera H, Lunell N-O, Seiger Å (1993) Neurochemical differentiation of human bulbospinal monoaminergic neurons during the first trimester. Dev Brain Res 75(1):1–12CrossRef

Sutterland AL, Kuin A, Kuiper B, van Gool T, Leboyer M, Fond G, de Haan L (2019) Driving us mad: the association of Toxoplasma gondii with suicide attempts and traffic accidents - a systematic review and meta-analysis. Psychol Med 49(10):1608–1623. https://doi.org/10.1017/s0033291719000813CrossRefPubMed

Sutterland AL, Fond G, Kuin A, Koeter MW, Lutter R, van Gool T, Yolken R, Szoke A, Leboyer M, de Haan L (2015) Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis. Acta Psychiatr Scand 132(3), 161–179. https://doi.org/10.1111/acps.12423

Suzuki Y (2002) Immunopathogenesis of cerebral toxoplasmosis. J Infect Dis 186(Suppl 2):S234-240. https://doi.org/10.1086/344276CrossRefPubMed

Suzuki Y, Sa Q, Gehman M, Ochiai E (2011) Interferon-gamma-and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain. Expert Rev Mol Med 13:e31. https://doi.org/10.1086/344276CrossRefPubMedPubMedCentral

Swift RG, Polymeropoulos MH, Torres R, Swift M (1998) Predisposition of Wolfram syndrome heterozygotes to psychiatric illness. Mol Psychiatry 3:86–91CrossRef

Tan L, Yu JT, Tan L (2012) The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations. J Neurol Sci 323(1–2), 1–8. https://doi.org/10.1016/j.jns.2012.08.005

Taupin P (2007). The hippocampus: neurotransmission and plasticity in the nervous system. Nova Publishers.

Tedford E, McConkey G (2017) Neurophysiological changes induced by chronic Toxoplasma gondii infection. Pathogens 6(2). https://doi.org/10.3390/pathogens6020019

Tenter AM, Heckeroth AR, Weiss LM (2000) Toxoplasma gondii: from animals to humans. J Int J Parasitol 30(12–13):1217–1258. https://doi.org/10.1016/S0020-7519(00)00124-7CrossRef

Tipton KF, Dostert P, Strolin Benedetti M (1984) Monoamine oxidase and disease. Academic, London

Tiwari P, Dwivedi S, Singh MP, Mishra R, Chandy A (2013) Basic and modern concepts on cholinergic receptor: a review. Asian Pac J Trop Dis 3(5):413–420. https://doi.org/10.1016/S2222-1808(13)60094-8CrossRefPubMedCentral

Tonin AA, da Silva AS, Thorstenberg ML, Castilhos LG, França RT, Leal DBR, Duarte MMMF, Vogel FSF, de La Rue ML, dos Anjos Lopes ST (2013) Influence of Toxoplasma gondii acute infection on cholinesterase activities of Wistar rats. Korean J Parasitol 51(4):421. https://doi.org/10.3347/kjp.2013.51.4.421CrossRefPubMedPubMedCentral

Tonin AA, Da Silva AS, Thomé GR, Sangoi MB, Oliveira LS, Flores MM, Schetinger MRC, Fighera RA, Moresco RN, Camillo G (2014) Influence of toxoplasmosis on acetylcholinesterase activity, nitric oxide levels and cellular lesion on the brain of mice. Pathol Res Pract 210(8):526–532. https://doi.org/10.1016/j.prp.2014.04.025CrossRefPubMed

Torrey EF, Yolken RH (2003) Toxoplasma gondii and schizophrenia. Emerging Infect Dis 9(11):1375. https://doi.org/10.3201/eid0911.030143CrossRef

Torrey EF, Bartko JJ, Lun ZR, Yolken RH (2007) Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull 33(3):729–736. https://doi.org/10.1093/schbul/sbl050CrossRefPubMed

Treiman DM (2001) GABAergic mechanisms in epilepsy. Epilepsia 42:8–12. https://doi.org/10.1046/j.1528-1157.2001.042suppl.3008.xCrossRefPubMed

Tyebji S, Seizova S, Hannan AJ, Tonkin CJ (2019) Toxoplasmosis: a pathway to neuropsychiatric disorders. Neurosci Biobehav Rev 96:72–92. https://doi.org/10.1016/j.neubiorev.2018.11.012CrossRefPubMed

van Staden JF, van Staden RI (2012) Flow-injection analysis systems with different detection devices and other related techniques for the in vitro and in vivo determination of dopamine as neurotransmitter. A Review Talanta 102:34–43. https://doi.org/10.1016/j.talanta.2012.05.017CrossRefPubMed

Vyas A (2015) Mechanisms of host behavioral change in Toxoplasma gondii rodent association. PLoS Pathog 11(7):e1004935. https://doi.org/10.1371/journal.ppat.1004935CrossRefPubMedPubMedCentral

Wagner MJ, Kim TH, Savall J, Schnitzer MJ, Luo L (2017) Cerebellar granule cells encode the expectation of reward. Nature 544(7648):96–100. https://doi.org/10.1038/nature21726CrossRefPubMedPubMedCentral

Waly M, Olteanu H, Banerjee R, Choi SW, Mason JB, Parker BS, Sukumar S, Shim S, Sharma A, Benzecry JM, Power-Charnitsky VA, Deth RC (2004) Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal. Mol Psychiatry 9(4):358–370. https://doi.org/10.1038/sj.mp.4001476CrossRefPubMed

Wanet A, Tacheny A, Arnould T, Renard P (2012) miR-212/132 expression and functions: within and beyond the neuronal compartment. Nucleic Acids Res 40(11):4742–4753. https://doi.org/10.1093/nar/gks151CrossRefPubMedPubMedCentral

Wang F, Lidow MS (1997) α2A-adrenergic receptors are expressed by diverse cell types in the fetal primate cerebral wall. J Comp Neurol 378(4):493–507CrossRef

Wang Y-M, Xu F, Gainetdinov RR, Caron MG (1999) Genetic approaches to studying norepinephrine function: knockout of the mouse norepinephrine transporter gene. Biol Psychiatry 46(9):1124–1130. https://doi.org/10.1016/s0006-3223(99)00245-0CrossRefPubMed

Wang HL, Wang GH, Li QY, Shu C, Jiang MS, Guo Y (2006) Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. Acta Psychiatr Scand 114(1):40–48. https://doi.org/10.1111/j.1600-0447.2006.00780.xCrossRefPubMed

Wang T, Tang Z-h, Li J-f, Li X-n, Wang X, Zhao Z-j (2013) A potential association between Toxoplasma gondii infection and schizophrenia in mouse models. Exp Parasitol 135(3):497–502. https://doi.org/10.1016/j.exppara.2013.08.012CrossRefPubMed

Wang ZT, Harmon S, O’Malley KL, Sibley LD (2015) Reassessment of the role of aromatic amino acid hydroxylases and the effect of infection by Toxoplasma gondii on host dopamine. Infect Immun 83(3):1039–1047. https://doi.org/10.1128/iai.02465-14CrossRefPubMedPubMedCentral

Wang ZT, Verma SK, Dubey JP, Sibley LD (2017) The aromatic amino acid hydroxylase genes AAH1 and AAH2 in Toxoplasma gondii contribute to transmission in the cat. PLoS Pathog 13(3):e1006272. https://doi.org/10.1371/journal.ppat.1006272CrossRefPubMedPubMedCentral

Wang T, Sun X, Qin W, Zhang X, Wu L, Li Y, Zhou C, Zhou H, He S, Cong H (2019) From inflammatory reactions to neurotransmitter changes: Implications for understanding the neurobehavioral changes in mice chronically infected with Toxoplasma gondii. Behav Brain Res 359:737–748. https://doi.org/10.1016/j.bbr.2018.09.011CrossRefPubMed

Webster JP, Lamberton PH, Donnelly CA, Torrey EF (2006) Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii’s ability to alter host behaviour. Proc Biol Sci 273(1589):1023–1030. https://doi.org/10.1098/rspb.2005.3413CrossRefPubMedPubMedCentral

West AR, Galloway MP, Grace AA (2002) Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms. Synapse 44(4):227–245. https://doi.org/10.1002/syn.10076CrossRefPubMed

White K, Shih J, Fong T, Young H, Gelfand R, Boyd J, Simpson G, Sloane R (1980) Elevated platelet monoamine oxidase activity in patients with nonendogenous depression. Am J Psychiatry 137:1258–1259. https://doi.org/10.1176/ajp.137.10.1258CrossRefPubMed

Wohlfert EA, Blader IJ, Wilson EH (2017) Brains and brawn: Toxoplasma infections of the central nervous system and skeletal muscle. Trends Parasitol 33(7):519–531. https://doi.org/10.1016/j.pt.2017.04.001CrossRefPubMedPubMedCentral

Wolfe N, Katz DI, Albert ML, Almozlino A, Durso R, Smith MC, Volicer L (1990) Neuropsychological profile linked to low dopamine: in Alzheimer’s disease, major depression, and Parkinson’s disease. J Neurol Neurosurg Psychiatry 53(10):915–917. https://doi.org/10.1136/jnnp.53.10.915CrossRefPubMedPubMedCentral

Wonodi I, Schwarcz R (2010) Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in schizophrenia. Schizophr Bull 36(2):211–218. https://doi.org/10.1093/schbul/sbq002CrossRefPubMedPubMedCentral

Wyatt RJ, Murphy DL (1976) Low platelet monoamine oxidase activity and schizophrenia. Schizophr Bull 2(1):77. https://doi.org/10.1093/schbul/2.1.77CrossRefPubMed

Xiao J, Li Y, Prandovszky E, Karuppagounder SS, Talbot CC Jr, Dawson VL, Dawson TM, Yolken RH (2014) MicroRNA-132 dysregulation in Toxoplasma gondii infection has implications for dopamine signaling pathway. Neuroscience 268:128–138. https://doi.org/10.1016/j.neuroscience.2014.03.015CrossRefPubMed

Xiao J, Li Y, Prandovszky E, Kannan G, Viscidi RP, Pletnikov MV, Yolken RH (2016) Behavioral abnormalities in a mouse model of chronic toxoplasmosis are associated with MAG1 antibody levels and cyst burden. PLOS Negl Trop Dis 10(4):e0004674. https://doi.org/10.1371/journal.pntd.0004674CrossRefPubMedPubMedCentral

Xu F, Gainetdinov RR, Wetsel WC, Jones SR, Bohn LM, Miller GW, Wang Y-M, Caron MG (2000) Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat Neurosci 3(5):465–471. https://doi.org/10.1038/74839CrossRefPubMed

Xu M-J, Zhou D-H, Nisbet AJ, Huang S-Y, Fan Y-F, Zhu X-Q (2013) Characterization of mouse brain microRNAs after infection with cyst-forming Toxoplasma gondii. Parasites Vectors 6:154. https://doi.org/10.1186/1756-3305-6-154CrossRefPubMedPubMedCentral

Yang D, Li T, Wang Y, Tang Y, Cui H, Tang Y, Zhang X, Chen D, Shen N, Le W (2012) miR-132 regulates the differentiation of dopamine neurons by directly targeting Nurr1 expression. J Cell Sci 125(Pt 7):1673–1682. https://doi.org/10.1242/jcs.086421CrossRefPubMed

Yap G, Pesin M, Sher A (2000) Cutting edge: IL-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen Toxoplasma Gondii. J Immunol 165(2):628–631. https://doi.org/10.4049/jimmunol.165.2.628CrossRefPubMed

Yarovinsky F (2014) Innate immunity to Toxoplasma gondii infection. Nat Rev Immunol 14(2):109–121. https://doi.org/10.1038/nri3598CrossRefPubMed

Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, Hayden MS, Hieny S, Sutterwala FS, Flavell RA, Ghosh S, Sher A (2005) TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308:1626–1629. https://doi.org/10.1126/science.1109893CrossRefPubMed

Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, Anisman H, Greenberg AH (1994) Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res 643(1–2):40–49. https://doi.org/10.1016/0006-8993(94)90006-xCrossRefPubMed

Zhang YH, Chen H, Chen Y, Wang L, Cai YH, Li M, Wen HQ, Du J, An R, Luo QL, Wang XL, Lun ZR, Xu YH, Shen JL (2014) Activated microglia contribute to neuronal apoptosis in toxoplasmic encephalitis. Parasit Vectors 7:372. https://doi.org/10.1186/1756-3305-7-372CrossRefPubMedPubMedCentral

Zhang Y, Tan F, Xu P, Qu S (2016) Recent advance in the relationship between excitatory amino acid transporters and Parkinson’s disease. Neural Plast 2016.https://doi.org/10.1155/2016/8941327

Zhu CB, Carneiro AM, Dostmann WR, Hewlett WA, Blakely RD (2005) p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. J Biol Chem 280(16):15649–15658. https://doi.org/10.1074/jbc.M410858200CrossRefPubMed

Zhu CB, Lindler KM, Owens AW, Daws LC, Blakely RD, Hewlett WA (2010) Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology 35(13):2510–2520. https://doi.org/10.1038/npp.2010.116CrossRefPubMedPubMedCentral

Zimmerman AW, Jyonouchi H, Comi AM, Connors SL, Milstien S, Varsou A, Heyes MP (2005) Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol 33(3):195–201. https://doi.org/10.1016/j.pediatrneurol.2005.03.014CrossRefPubMed

Feigin VLAA, Abate KH, Abd-Allah F, Abdulle AM, Abera SF, Abyu GY, Vos T (2017) Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Neurol 16(11):877–97. https://doi.org/10.1016/s1474-4422(17)30299-5CrossRef

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Toxoplasmosis: Targeting neurotransmitter systems in psychiatric disorders

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Sozialer Aufstieg verringert Demenzgefahr

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

Thrombektomie auch bei großen Infarkten von Vorteil

Update Neurologie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Circular RNA circLIFR regulates the proliferation, migration, invasion and apoptosis of human vascular smooth muscle cells via the miR-1299/KDR axis

Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration

Immune-microbiome interplay and its implications in neurodegenerative disorders

Possible involvement of NO-sGC-cGMP signaling in the antidepressant like effect of pyridoxine in mice

MALDI imaging mass spectrometry: an emerging tool in neurology